Company · CIK 1797768
Kinnate Biopharma Inc.
| CIK | 1797768 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-03-29 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-261970 | 2022-01-03 | 2022-04-26 | 2 | |
| 333-250086 | 2020-11-13 | 2020-12-03 | 5 |
Filings
8| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2022-04-26 | EFFECTDeclared effective | 333-261970 | 9999999995-22-001087 |
| 2022-01-03 | S-3ASRShelf registered | 333-261970 | 0001140361-22-000057 |
| 2020-12-03 | 424B4Final prospectus | 333-250086 | 0001140361-20-027255 |
| 2020-12-02 | EFFECTDeclared effective | 333-250086 | 9999999995-20-003367 |
| 2020-12-02 | S-1/AAmendment | 333-250086 | 0001140361-20-027054 |
| 2020-11-30 | S-1/AAmendment | 333-250086 | 0001140361-20-026755 |
| 2020-11-13 | S-1Registration filed | 333-250086 | 0001140361-20-025527 |
| 2020-09-04 | DRSDraft made public | 377-03501 | 0001140361-20-019819 |